Tags » Pharmaceutical Industry

The fall of a major specialty pharmacy


Diplomat Pharmacy, which sells medications to people with complex conditions and acts as a drug benefit middleman, is a shell of itself. The company was worth more than $3 billion in its heyday in 2015, but is now worth a little more than $200 million after a  195 more words

High Drug Prices

Health Beat: Patients Seeking Pain Relief Should Not Be Treated As Criminals

Stephanie Deegan is one of many patients who cannot get opioids as easily, but she still needs help for severe pain.

By Kathleen Kozak November 8, 2019 Reading time: 5 minutes. 1,057 more words


Should Clinical Trial Data Be Publicly Available?

The Canadian Department of Health has recently made a decision to allow the public to access the clinical trial data that “companies submit when seeking approval for a new drug, biological treatment, or medical device.” Though drug manufacturers can negotiate possible redactions of the data with Health Canada, Health Canada retains ultimate control over what information gets redacted and what information is published in reports. 171 more words


Elizabeth Warren’s $20.5 Trillion Plan to Fund Medicare for All


Elizabeth Warren on Friday detailed how she intends to pay for Medicare for All without raising costs for middle-class households. The senator from Massachusetts said her plan will cover everyone in the country without raising overall spending, “while putting $11 trillion back in the pockets of the American people by eliminating premiums and virtually eliminating out-of-pocket costs.” 1,165 more words

Health Policy